Hôpital Saint-Louis, Service d'Hématologie

Paris, IDF 75475

0 studies enrolling now · 2 studies all time

What they study most

Chronic Myelomonocytic Leukemia, Cytopenia, Myelodysplastic Syndromes, Refractory Anemia With Excess Blasts

Studies at this site

• Oral Rigosertib in Low Risk MDS Patients Refractory to ESAs — Completed
• Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine — Completed